Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...
Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...
T-797 enables tumor-cell killing in a human relevant model of checkpoint inhibitor–resistant colorectal cancer liver metastasesNative and ...
Lung cancer treatment has entered a paradoxical era: more options than ever, and harder decisions than ever. For patients with advanced non-small cell lung cancer driven by mutations in the epidermal ...
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder ...
One of the most frustrating realities in liver cancer treatment is that even after a seemingly successful surgical resection, ...
Broad RNA profiling could turn a noninvasive urine sample into a tool for characterizing bladder tumors and guiding personalized treatment decisions.
AI-enabled digital pathology analysis shows aglatimagene significantly increased lymphocyte infiltration and immune engagement with tumor cells ...
Surgery, Treatment Updates, and What Remains Unknown / Breast Cancer, breast cancer surgery, breast cancer treatment, ...
Open-source oncology tools span patient-facing trackers and explainers, genomics-to-therapy ranking systems, and LLMs ...
A genetic vulnerability in clear cell renal cell carcinoma, the most aggressive type of kidney cancer, may lend itself to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results